Thermodynamic dissociation constants of alendronate and ibandronate by regression analysis of potentiometric data

Journal of Chemical and Engineering Data

Volumn 56, Issue 10, 2011, Pages 3848-3854

  Meloun, Milan ^a   Ferenčíková, Zuzana ^a   Netolická, Lucie ^a   Pekárek, Tomáš ^b  

^a UNIVERSITY OF PARDUBICE   (Czech Republic)

^b Zentiva Prague   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONATE; BISPHOSPHONATES; BONE RESORPTION; COMPUTATIONAL STRATEGY; DISSOCIATION CONSTANT; EXTERNAL CALIBRATION; GLASS ELECTRODES; GOODNESS-OF-FIT TEST; GROUP PARAMETERS; HIGH POTENCY; ILL-CONDITIONED; NON-LINEAR REGRESSION; POTENTIOMETRIC DATA; POTENTIOMETRIC TITRATIONS; REGRESSION DIAGNOSTICS; RELIABILITY OF PARAMETERS; RELIABLE ESTIMATES; THERMODYNAMIC DISSOCIATION CONSTANTS;

ESTIMATION; IONIC STRENGTH; PARAMETER ESTIMATION; POTENTIOMETERS (ELECTRIC MEASURING INSTRUMENTS); REFINING; REGRESSION ANALYSIS; TITRATION; VOLTAMMETRY;

DISSOCIATION;

EID: 80054699602     PISSN: 00219568     EISSN: 15205134     Source Type: Journal    
DOI: 10.1021/je200512e     Document Type: Article

References (47)

1. Fleisch, H. Bisphosphonates: Mechanisms of action Endocr. Rev. 1998, 19, 80-100 (Pubitemid 29122075)
2. Fleisch, H. Development of bisphosphonates Breast Cancer Res. 2002, 4, 30-34 (Pubitemid 34097554)
3. Hounslow, A. M.; Carran, J.; Brown, R. J.; Rejman, D.; Blackburn, G. M.; Watts, D. J. Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs J. Med. Chem. 2008, 51, 4170-4178 (Pubitemid 352032442)
4. Fleisch, H. Bisphosphonates in bone disease: from the laboratory to the patient; Parthenon Publishing Group: Nashville, TN, 1995.
5. Russell, R. G. Bisphosphonates: from bench to bedside Ann. N.Y. Acad. Sci. 2006, 1068, 367-401 (Pubitemid 43824169)
6. Rogers, M. J.; Watts, D. J.; Russell, R. G.; Ji, X.; Xiong, X.; Blackburn, G. M.; Bayless, A. V.; Ebetino, F. H. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum J. Bone Miner. Res. 1994, 9, 1029-39 (Pubitemid 24191790)
7. Rogers, M. J.; Xiong, X.; Brown, R. J.; Watts, D. J.; Russell, R. G.; Bayless, A. V.; Ebetino, F. H. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae Mol. Pharmacol. 1995, 47, 398-402
8. Grove, J. E.; Brown, R. J.; Watts, D. J. The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase J. Bone Miner. Res. 2000, 15, 971-81 (Pubitemid 30233423)
9. Russell, R. G. Ibandronate: pharmacology and preclinical studies Bone 2006, 38, S7-12
10. Nancollas, G. H.; Tang, R.; Phipps, R. J.; Henneman, Z.; Gulde, S.; Wu, W.; Mangood, A.; Russell, R. G.; Ebetino, F. H. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite Bone 2006, 38, 617-27
11. Dunford, J. E.; Kwaasi, A. A.; Rogers, M. J.; Barnett, B. L.; Ebetino, F. H.; Russell, R. G.; Oppermann, U.; Kavanagh, K. L. Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase J. Med. Chem. 2008, 51, 2187-95 (Pubitemid 351503274)
12. Hodgson, S. F.; Watts, N. B.; Bilezikian, J. P.; Clarke, B. L.; Gray, T. K.; Harris, D. W.; Johnston, C. C.; Kleerekoper, M.; Lindsay, R.; Luckey, M. M.; McClung, M. R.; Nankin, H. R.; Petak, S. M.; Recker, R. R. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003 Endocr. Pract. 2003, 9, 544-64
13. Chesnut, C. H.; Skag, A.; Christiansen, C.; Recker, R.; Stakkestad, J. A.; Hoiseth, A.; Felsenberg, D.; Huss, H.; Gilbride, J.; Schimmer, R. C.; Delmas, P. D.; Vert, O. I. O. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis J. Bone Miner. Res. 2004, 19, 1241-1249 (Pubitemid 41094364)
14. Bone, H. G.; Hosking, D.; Devogelaer, J.; Tucci, J. R.; Emkey, R. D.; Tonino, R. P.; Rodriguez-Portales, J. A.; Downs, R. W.; Gupta, J.; Santora, A. C.; Liberman, U. A. Ten years' experience with alendronate for osteoporosis in postmenopausal women N. Eng. J. Med. 2004, 350, 1189-1199 (Pubitemid 38339363)
15. McClung, M. R.; Geusens, P.; Miller, P. D.; Zippel, H.; Bensen, W. G.; Roux, C.; Adami, S.; Fogelman, I.; Diamond, T.; Eastell, R.; Meunier, P. J.; Reginster, J. Y.; Wasnich, R. D.; Greenwald, M.; Kaufman, J.; Chestnut, C. H. Effect of risedronate on the risk of hip fracture in elderly women N. Engl. J. Med. 2001, 344, 333-340 (Pubitemid 32107641)
16. Bock, O.; Felsenberg, D. Bisphosphonates in the management of postmenopausal osteoporosis - optimizing efficacy in clinical practice Clin. Interv. Aging 2008, 3, 279-97 (Pubitemid 352037868)
17. Van Beek, E.; Lowik, C.; Que, I.; Papapoulos, S. Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group J. Bone Miner. Res. 1996, 11, 1492-7 (Pubitemid 26331004)
18. Shinoda, H.; Adámek, G.; Felix, R.; Fleisch, H.; Schenk, R.; Hagan, P. Structure-activity relationships of various bisphosphonates Calcif. Tissue Int. 1983, 35, 87-99 (Pubitemid 13193154)
19. Geddes, A. D.; D'Souza, S. H.; Ebetino, F. H.; Ibbotson, K. J. Bisphosphonates: structure-activity relationships and therapeutic implications. In Bone Mineral Research; Heersche, J. N. M.; Kanis, J. A., Eds.; Elsevier: Amsterdam, 1994; Vol. 8, pp 265-306.
20. Lawson, M. A.; Triffitt, J. T.; Ebetino, F. H.; Barnett, B. L.; Phipps, R. J.; White, D. J.; Russell, R. G. G. Differences in the potential binding of phosphate containing compounds to bone mineral are revealed by the novel use of hydroxyapatite column chromatography J. Bone. Miner. Res. 2005, 20, 1303-1303
21. Green, J. R.; Muller, K.; Jaeggi, K. A. Preclinical Pharmacology of Cgp 42′446, a New, Potent, Heterocyclic Bisphosphonate Compound J. Bone Miner. Res. 1994, 9, 745-751 (Pubitemid 24130477)
22. Boichenko, A. P.; Markov, V. V.; Kong, H. L.; Matveeva, A. G.; Loginova, L. P. Re-evaluated data of dissociation constants of alendronic, pamidronic and olpadronic acids Cent. Eur. J. Chem. 2009, 7, 8-13
23. Dyba, M.; Jezowska-Bojczuk, M.; Kiss, E.; Kiss, T.; Kozlowski, H.; Leroux, Y.; El Manouni, D. 1-Hydroxyalkane-1,1-diyldiphosphonates as potent chelating agents for metal ions. Potentiometric and spectroscopic studies of copper(II) coordination J. Chem. Soc., Dalton. Trans. 1996, 1119-1123 (Pubitemid 126787218)
24. Kabachnik, M. I.; Medved, T. Y.; Dyaglova, N. M.; Polikarpov, Y. M.; Shcherbakov, B. K.; Belskii, F. I. Synthesis and Acid-Base and Complexing Properties of Amino-Substituted "Alpha-Hydroxyalkylidenediphosphonic Acids" Bull. Acad. Sci. USSR Div. Chem. Sci. 1978, 27, 374-377
25. Hägele, G.; Szakacs, Z.; Ollig, J.; Hermens, S.; Pfaff, C. NMR-controlled titrations: Characterizing aminophosphonates and related structures Heteroatom Chem. 2000, 11, 562-582 (Pubitemid 32074848)
26. Meloun, M.; Havel, J.; Högfeldt, E. Computation of solution equilibria: a guide to methods in potentiometry, extraction, and spectrophotometry; Ellis Horwood: Chichester, U.K., 1988.
27. Meloun, M.; Bartoš, M.; Högfeldt, E. Multiparametric curve fitting-XIII Reliability of formation constants determined by analysis of potentiometric titration data Talanta 1988, 35, 981-91
28. Rigano, C.; Grasso, M.; Sammartano, S. Computer-Analysis of Equilibrium Data in Solution-a Compact Least-Squares Computer-Program for Acid-Base Titrations Ann. Chim. 1984, 74, 537-532
29. De Stefano, C.; Princi, P.; Rigano, C.; Sammartano, S. Computer analysis of equilibrium data in solution ESAB2M: an improved version of the ESAB program Ann. Chim. 1987, 77, 643-675
30. Capone, S.; Derobertis, A.; Destefano, C.; Sammartano, S.; Scarcella, R. Ionic-Strength Dependence of Formation-Constants 0.10. Proton Activity-Coefficients at Various Temperatures and Ionic Strengths and Their Use in the Study of Complex Equilibria Talanta 1987, 34, 593-598
31. Gans, P.; Sabatini, A.; Vacca, A. Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs Talanta 1996, 43, 1739-1753 (Pubitemid 26351353)
32. Meloun, M.; Militký, J.; Forina, M. Chemometrics for analytical chemistry, Vol. 2: PC-aided regression and related methods; Ellis Horwood: Chichester, 1994; p 400.
33. Meloun, M.; Militký, J.; Forina, M. Chemometrics for analytical chemistry, Vol. 1: PC-Aided Statistical Data Analysis; Ellis Horwood: Chichester, 1992; p 330.
34. Meloun, M.; Říha, V.; Žáček, J. Piston Microburette for Dosing Aggressive Liquids Chem. Listy 1988, 82, 765-767
35. May, P. M.; Williams, D. R.; Linder, P. W.; Torrington, R. G. The Use of Glass Electrodes for the Determination of Formation-Constants 0.1. A Definitive Method for Calibration Talanta 1982, 29, 249-256
36. ADSTAT 1.25, 2.0, 3.0 (Windows 95); TriloByte Statistical Software Ltd.: Pardubice, Czech Republic, 1995.
37. Gulyás, Z.; Pöcze, G.; Petz, A.; Darvas, F. PALLAS 3.0; CompuDrug International Inc.: San Francisco, CA, 1994. http://www.compudrug.com.
38. Meloun, M.; Bordovská, S.; Kupka, K. Outliers detection in the statistical accuracy test of a pK(a) prediction J. Math. Chem. 2010, 47, 891-909
39. Szegezdi, J.; Csizmadia, F. Prediction of dissociation constant using microconstants; ChemAxon: Hungary, 1998-2011. http://www.chemaxon.com/marvin.
40. Rondeau, J. M.; Bitsch, F.; Bourgier, E.; Geiser, M.; Hemmig, R.; Kroemer, M.; Lehmann, S.; Ramage, P.; Rieffel, S.; Strauss, A.; Green, J. R.; Jahnke, W. Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs ChemMedChem 2006, 1, 267-273 (Pubitemid 43700307)
41. Tripathi, K. D. Pharmacological Classification of Drugs; Jaypee Brothers Medical Publishing: New Delhi, 2006.
42. Index, T. M. Merck Index; Merck Co., Inc.: Whitehouse Station, NJ, 2010.
43. Karamustafa, F.; Celebi, N. Bisphosphonates and Alendronate FABAD J. Pharm. Sci 2006, 31, 31-42 (Pubitemid 351596127)
44. Nancollas, G. H.; Tang, R.; Phipps, R. J.; Henneman, Z.; Gulde, S.; Wu, W.; Mangood, A.; Russell, R. G. G.; Ebetino, F. H. Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite Bone 2006, 38, 617-627
45. 2+ with aminopropylidenebisphosphonic acids in aqueous and micellar solution of cetylpyridinium chloride J. Mol. Liq. 2010, 154, 76-81
46. Boichenko, A. P.; Sidorenko, A. Yu.; Markov, V. V.; Cong, H. L.; Matveeva, A. G.; Loginova, L. P. Effect of micellar media Brij 35 on protolytic properties of series of aminodiphposphonic acids Kharkov Univ. Bull. 2010, 895, 56-64
47. Meloun, M.; Ferenčíková, Z.; Netolická, L.; Vrána, A. The thermodynamic dissociation constant of naphazoline by the regression analysis of potentiometric data Cent. Eur. J. Chem. 2011, 9, 66-74